This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MARCEL GOLDENBERG, M.D.; HENRY ARANOW, Jr., M.D.; ALFRED A. SMITH, M.S.; MOGENS FABER, M.D.

Arch Intern Med. 1950;86(6):823-836.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THAT essential hypertensive vascular disease may be clinically indistinguishable from the syndrome presented by certain patients with pheochromocytoma has been frequently and properly emphasized in recent years.¹ The pharmacologic actions of epinephrine, the only pressor agent which had been demonstrated in these neoplasms, could account for the so-called adrenal-sympathetic syndrome associated with paroxysmal hypertension but were hard to reconcile with a hemodynamic picture resembling essential hypertensive vascular disease. When epinephrine is infused into a normal man at a rate sufficient to produce a systolic blood pressure of 180 mm. Hg, there is usually no significant elevation of diastolic pressure, and the infusion is accompanied with a number of unpleasant symptoms, such as anxiety and palpitation; further increase in the rate of epinephrine administration is often marked by the appearance of extrasystoles, restlessness and hyperpnea. Another striking variance from the picture of essential hypertensive vascular disease is the fact that . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Department of Medicine, College of Physicians and Surgeons, Columbia University, and the Presbyterian Hospital in the City of New York.

Footnotes
This work was supported by a grant from the Life Insurance Medical Research Fund.

Life Insurance Research Fellow, Department of Biochemistry. Present address, Bispebjerg Hospital, Copenhagen, Denmark.

This paper was presented in part at the Annual Meeting of the Society for Clinical Investigation, Atlantic City, N. J., May 1, 1950.

Portions of the tumors and abstracts for these studies were supplied by Drs. F. C. Bartter, United States Public Health Service; H. Gordon, New York; L. Leiter, New York; H. D. Moon, Veterans Administration, San Francisco; C. W. Robertson, Boston; R. H. Smithwick, Boston; S. B. Straus, New York; D. O. Thompson, Atlanta, Ga., and N. V. Treger, Evanston, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?